CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
about
Genetically Engineered Phages: a Review of Advances over the Last DecadeThe Bacteriophage Carrier State of Campylobacter jejuni Features Changes in Host Non-coding RNAs and the Acquisition of New Host-derived CRISPR Spacer SequencesFunctional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome EngineeringCRISPR RNA binding and DNA target recognition by purified Cascade complexes from Escherichia coliEngineering Modular Viral Scaffolds for Targeted Bacterial Population Editing.DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes.Genetically modified bacteriophages.CrisprGE: a central hub of CRISPR/Cas-based genome editing.Phage Therapy in the Era of Synthetic Biology.Detecting natural adaptation of the Streptococcus thermophilus CRISPR-Cas systems in research and classroom settings.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.A decade of discovery: CRISPR functions and applications.Strategies for editing virulent staphylococcal phages using CRISPR-Cas10.Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9.CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity.Klebsiella Phage ΦK64-1 Encodes Multiple Depolymerases for Multiple Host Capsular Types.Long-term microbiota and virome in a Zürich patient after fecal transplantation against Clostridium difficile infection.Programming Native CRISPR Arrays for the Generation of Targeted Immunity.Selection of Genetically Modified Bacteriophages Using the CRISPR-Cas System.Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria.Immune loss as a driver of coexistence during host-phage coevolution.Incomplete prophage tolerance by type III-A CRISPR-Cas systems reduces the fitness of lysogenic hosts.A technological and regulatory outlook on CRISPR crop editing.Unexpected evolutionary benefit to phages imparted by bacterial CRISPR-Cas9.Development of a versatile Cas9-driven subpopulation-selection toolbox in Lactococcus lactis.Silk Route to the Acceptance and Re-Implementation of Bacteriophage Therapy-Part II.A CRISPR-Cas9-Based Toolkit for Fast and Precise In Vivo Genetic Engineering of Bacillus subtilis Phages.
P2860
Q26744156-4BF6F960-834C-4F7F-8987-63666A7D30ABQ26752309-41BE0012-1D40-4D5F-907E-F366A7A3F531Q30381756-931264C3-9801-46D7-9A63-C1E34D00CFE4Q34883272-67D9BD01-6BCC-4ACD-940D-39FA4844846CQ36672110-D24F2294-0359-4566-80FD-D188DBFB2A23Q38454128-8146CCE7-9C2E-4C3A-AA19-0AF36682364AQ38746993-DB681F14-F30E-42BA-8F60-5CD54212116AQ38859113-3FCB4204-9DAE-4E35-A6B9-E8689F5A5935Q38915649-F6866811-4405-495A-8389-33AE47A6E2D3Q38957867-1719A7BF-DD0F-42BD-B779-5401C1744B77Q39029801-F724DBE3-D5FC-4C91-BEFD-BE3EC27E4BDBQ39350951-517B6963-076B-4A43-86B8-9EDEBA8FB269Q40051003-A97BBFF4-E919-472B-98D9-1980505FF7F6Q40155162-6F23289F-7CA9-4757-A22E-504467E1F057Q40268797-5259DDA8-2115-4E75-8251-D1461D95A37DQ40375892-F0F1F7E2-76E6-4E6F-ADFC-EEA6ACC8D7F0Q40708125-2BA4DDDD-7BDE-4933-ACFC-21FF5870B2EDQ40770181-7F71904A-E754-4769-A61A-43089B6B70DEQ41361781-443BBB35-3B37-4855-9487-0C36B414F222Q47202168-445E08BD-122C-4ACD-8D9A-842EDD5A8272Q47554536-FA1F8618-7E20-4782-BB37-3BA17B17F1C2Q47557983-4E337691-5D26-4FB2-9109-425684B84FA5Q47898288-4FB87B52-22B6-49F2-94C0-3B666EE76213Q49864566-1E2AA4E0-E414-4BFB-ADCF-0B45E3538202Q49914389-6DE6ED34-6414-4994-A351-9D2D7842B57EQ52431831-6BB1D2BA-EBEA-4D3D-90E0-ADC921E6086DQ53686733-27413073-3A2B-4B4F-B8A5-DCFF1B0323A5
P2860
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
@ast
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
@en
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
@nl
type
label
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
@ast
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
@en
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
@nl
prefLabel
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
@ast
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
@en
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages.
@nl
P2860
P356
P1476
CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages
@en
P2093
Bruno Martel
P2860
P304
P356
10.1093/NAR/GKU628
P407
P577
2014-07-24T00:00:00Z